ClinicalTrials.Veeva

Menu

Impact of Diabetes-Related Metabolic Derangements on Clinical Outcomes in Hospitalized Patients With Chronic Kidney Disease

S

Sohag University

Status

Not yet enrolling

Conditions

Diabetic Chronic Kidney Disease Patients

Treatments

Behavioral: Primary aim 1. To assess the frequency of diabetes mellitus among hospitalized CKD patients. 2. To evaluate the frequency and types of metabolic abnormalities (e.g., hypoglycemia, diabetic ketoacidosi

Study type

Observational

Funder types

Other

Identifiers

NCT07354958
Soh-Med--25-12-5MS

Details and patient eligibility

About

This observational study will collect clinical and laboratory information from hospitalized patients with chronic kidney disease to identify diabetes mellitus and selected metabolic findings during hospitalization

Full description

Hospitalized adult patients with chronic kidney disease will be included in this observational study. Information routinely recorded during hospitalization will be collected. This information will include the presence of diabetes mellitus and laboratory values related to blood glucose levels, electrolyte levels, and acid base balance. No study related interventions will be performed.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age greater than or equal to 18 years
  • Known chronic kidney disease, defined as baseline estimated glomerular filtration rate less than 60 milliliters per minute per 1.73 square meters for at least 3 months, or documented chronic kidney disease stage 3 to 5 by prior medical records
  • Hospitalized for any medical reason
  • Consent provided

Exclusion criteria

  • Acute single episode of reversible acute kidney injury with previously normal renal function (no established chronic kidney disease)
  • Admission for palliative care or expected survival less than 24 hours
  • Pregnancy

Trial design

200 participants in 1 patient group

1. Diabetic CKD (known diagnosis or on antidiabetic therapy prior to admission). 2. Non-diabetic CKD
Treatment:
Behavioral: Primary aim 1. To assess the frequency of diabetes mellitus among hospitalized CKD patients. 2. To evaluate the frequency and types of metabolic abnormalities (e.g., hypoglycemia, diabetic ketoacidosi

Trial contacts and locations

1

Loading...

Central trial contact

Mohamed Mahmoud Rashad, Master Degree; Mahmoud Ibrahim Yousef, Associate Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems